DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Diamox (Acetazolamide) - Published Studies

 



Diamox Related Published Studies

Well-designed clinical trials related to Diamox (Acetazolamide)

The effects of sildenafil and acetazolamide on breathing efficiency and ventilatory control during hypoxic exercise. [2009.07]

A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial. [2009]

Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans. [2008.09]

Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment. [2008.06.15]

Low-dose acetylsalicylic Acid analog and acetazolamide for prevention of acute mountain sickness. [2008.03]

Prevention of acute mountain sickness by acetazolamide in Nepali porters: a double-blind controlled trial. [2006.06]

Effect of acetazolamide on leg endurance exercise at sea level and simulated altitude. [2006.06]

Antioxidants reverse depression of the hypoxic ventilatory response by acetazolamide in man. [2006.05.01]

Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial. [2006.03]

Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug. [2006.03]

Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. [2006.01.15]

Comparative efficacy of acetazolamide and apraclonidine in the control of intraocular pressure following phacoemulsification. [2006]

Acetazolamide: a treatment for chronic mountain sickness. [2005.12.01]

Influences of caffeine, acetazolamide and cognitive stimulation on cerebral blood flow velocities. [2005.05]

Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. [2005.02.14]

Feasibility study of serial lumbar puncture and acetazolamide combination in the management of elevated cerebrospinal fluid pressure in AIDS patients with cryptococcal meningitis in Uganda. [2005.01]

Well-designed clinical trials possibly related to Diamox (Acetazolamide)

Does the use of trypan blue during phacoemulsification affect the intraocular pressure? [2009.06]

Effect of antiglaucoma agents on postoperative intraocular pressure after cataract surgery with Viscoat. [2007.11]

Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollague (3696 m) in northern Chile. [2007.01]

Cerebrovascular reactivity following administration of mirtazapine in healthy probands--a randomized, placebo controlled double-blind clinical study. [2006.06]

Effects of the selective cyclooxygenase-2 inhibitor analgesic celecoxib on renal carbonic anhydrase enzyme activity: a randomized, controlled trial. [2006.05]

To compare argon laser peripheral iridoplasty (ALPI) against systemic medications in treatment of acute primary angle-closure: mid-term results. [2006.03]

Oral administration of prednisone to control refractory vertigo in Meniere's disease: a pilot study. [2005.09]

Medical control of intraocular pressure after phacoemulsification. [2005.03]

Treatment of pseudophakic cystoid macular oedema. [2005]

Other research related to Diamox (Acetazolamide)

Acetazolamide suppresses the prevalence of augmented breaths during exposure to hypoxia. [2009.08]

Delayed migraine-like headache in healthy volunteers after a combination of acetazolamide and glyceryl trinitrate. [2009.05.11]

Acetazolamide influences ocular pulse amplitude. [2009.04]

Acetazolamide as an adjunct to CPAP treatment: a case of complex sleep apnea in a patient on long-acting opioid therapy. [2009.02.15]

[Enlargement of cerebral infarction after CBF study with acetazolamide challenge: two case report] [2009.02]

Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide. [2009.02]

Preoperative cerebrovascular reactivity to acetazolamide measured by brain perfusion SPECT predicts development of cerebral ischemic lesions caused by microemboli during carotid endarterectomy. [2009.02]

A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial. [2009.01.10]

Subdural effusion complicating neonatal meningitis: successful treatment with acetazolamide. [2009.01]

Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer. [2009]

Pseudophakic macular edema and oral acetazolamide: an optical coherence tomography measurable, dose-related response. [2008.11]

Evaluating middle cerebral artery collateral blood flow reserve using acetazolamide transcranial Doppler ultrasound in patients with carotid occlusive disease. [2008.11]

Biowaiver monographs for immediate release solid oral dosage forms: acetazolamide. [2008.09]

Effect of acetazolamide on ventilatory response in subjects with chronic mountain sickness. [2008.08.31]

Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate. [2008.08]

Effect of acetazolamide on ventilatory response in subjects with chronic mountain sickness. [2008.06.17]

Usefulness of rate of increase in SPECT counts in one-day method of N-isopropyl-4-iodoamphetamine [123I] SPECT studies at rest and after acetazolamide challenge using a method for estimating time-dependent distribution at rest. [2008.06]

[Intracerebral steal after acetazolamide administration] [2008.05.30]

Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness. [2008.01]

Post-hypoxic unstable breathing in the C57BL/6J mouse: effects of acetazolamide. [2008]

[Contact dermatitis caused by acetazolamide under occlusion] [2007.12]

Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. [2007.11]

Is acetazolamide similar to topiramate for reversal of antipsychotic-induced weight gain? [2007.11]

Effects of acetazolamide on aerobic exercise capacity and pulmonary hemodynamics at high altitudes. [2007.10]

Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa. [2007.10]

EFFECTS OF ACETAZOLAMIDE ON AEROBIC EXERCISE CAPACITY AND PULMONARY HEMODYNAMICS AT HIGH ALTITUDES. [2007.07.05]

Acetazolamide therapy for hypochloremic metabolic alkalosis in pediatric patients with heart disease. [2007.07]

Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor. [2007.06.29]

Cerebral fat embolism syndrome causing brain death after long-bone fractures and acetazolamide therapy. [2007.06]

[What should we think? Should Diamox and pilocarpine continue to be prescribed?] [2007.05]

Effect of acetazolamide on pulmonary and muscle gas exchange during normoxic and hypoxic exercise. [2007.03.15]

Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia. [2007.02.01]

Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. [2007.01.05]

Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition. [2007.01]

Resolution of Chiari I malformation following acetazolamide therapy. [2007.01]

The additive effect of topical dorzolamide and systemic acetazolamide in pediatric glaucoma. [2006.10]

Stevens-Johnson syndrome associated with intravenous acetazolamide administration for evaluation of cerebrovascular reactivity. Case report. [2006.03]

CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid. [2006.02]

Morphometric and microscopic evaluation of the effect of solution of acetazolamide as an intracanal therapeutic agent in late reimplanted rat teeth. [2006.02]

Acetazolamide-mediated decrease in strong ion difference accounts for the correction of metabolic alkalosis in critically ill patients. [2006.02]

Acetazolamide improves cerebral oxygenation during exercise at high altitude. [2006.01]

Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. [2005.12.08]

Acetazolamide and corticosteroid therapy in complicated arachnoid cyst. [2005.12]

[Advantages of acetazolamide associated with anti-inflammatory medications in postoperative treatment of macular edema] [2005.12]

Effect of carbogen breathing and acetazolamide on optic disc PO2. [2005.11]

[Influence of acetazolamide given intraperitoneally on the latency to hyperbaric oxygen-induced convulsion of rats.] [2005.08.25]

Effects of tissue heterogeneity on cerebral vascular response to acetazolamide stress measured by an I-123-IMP autoradiographic method with single-photon emission computed tomography. [2005.06]

The use of acetazolamide in idiopathic intracranial hypertension during pregnancy. [2005.05]

The effect of i.v. L-NG methylarginine hydrochloride (L-NMMA: 546C88) on basal and acetazolamide (Diamox) induced changes of blood velocity in cerebral arteries and regional cerebral blood flow in man. [2005.05]

Acetazolamide, a carbonic anhydrase inhibitor, reverses inflammation-induced thermal hyperalgesia in rats. [2005.05]

Acetazolamide efficacy and tolerability in migraine with aura: a pilot study. [2005.04]

Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study. [2005.04]

Transient neurologic deficit after acetazolamide challenge for computed tomography perfusion imaging. [2005.03]

Long-term effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammation. [2005.02]

Other possibly related research studies

Global cerebral blood flow in relation to cognitive performance and reserve in subjects with mild memory deficits. [2006.11]

Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis pigmentosa. [2006.10]

Combined direct anastomosis and encephaloduroarteriogaleosynangiosis using inverted superficial temporal artery-galeal flap and superficial temporal artery-galeal pedicle in adult moyamoya disease. [2006.10]

Puberty as a risk factor for less favorable visual outcome in idiopathic intracranial hypertension. [2006.08]

Diode laser cycloablation in adult glaucoma: long-term results of a standard protocol and review of current literature. [2006.07]

Prognostic relevance of anamnestic and diagnostic parameters in low-frequency hearing impairment. [2006.08]

Changes in brain volume 2 years after extracranial-intracranial bypass surgery: A preliminary subanalysis of the Japanese EC-IC trial. [2006]

Infantile spinocerebellar ataxia type 6: relationship to episodic ataxia type 6. [2006.04]

Correlative assessment of cerebral blood flow obtained with perfusion CT and positron emission tomography in symptomatic stenotic carotid disease. [2006.10]

Subretinal neovascular membrane in idiopathic intracranial hypertension. [2006.03]

Quantitative evaluation of cerebrovascular reactivity in brain tissue by a refill kinetic method of transcranial ultrasonic perfusion imaging: a comparison with Doppler sonography. [2005]

The roles of nitric oxide and carbon dioxide gas in the neurotoxic actions of oxygen under pressure. [2005.09]

Idiopathic intracranial hypertension and sickle cell disease: two case reports. [2005.12]

Ischemic orbital compartment syndrome as a complication of spinal surgery in the prone position. [2006.01]

Carbonic anhydrase inhibitors and hypoxic pulmonary vasoconstriction. [2006.04.28]

Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1 : EAGLE Study report no. 1. [2006.08]

Non-operative management of benign intracranial hypertension presenting with complete visual loss and deafness. [2006]

Adenosine A1 receptor antagonist blunts urinary potassium excretion, but not renal hemodynamic effects, induced by carbonic anhydrase inhibitor in rats. [2006.02]

Recognition and management of complex sleep-disordered breathing. [2005.11]

Transverse sinus stenoses persist after normalization of the CSF pressure in IIH. [2005.10.11]

Postoperative IOP prophylaxis practice following uncomplicated cataract surgery: a UK-wide consultant survey. [2005.10.07]

Hypothesis: could Meniere's disease be a channelopathy? [2005.08]

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009